Reduction of Disease Activity in Patient with Relapsing-Remitting Multiple Sclerosis after Switching to Teriflunomide from Interferon Beta
2016 ◽
Vol 34
(1)
◽
pp. 77-79
2012 ◽
Vol 78
(Meeting Abstracts 1)
◽
pp. PD5.008-PD5.008
1997 ◽
Vol 103
(1)
◽
pp. 99
2013 ◽
Vol 115
◽
pp. S65-S69
◽